Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice

Clinical trial NCT05402059 · UNKNOWN

Trial details

NCT number: NCT05402059
Sponsor: MelanomaPRO, Russia
Status: UNKNOWN
Study type: OBSERVATIONAL

Melanoma Melanoma (Skin)Melanoma, Uveal Melanoma Stage IV Melanoma Stage III Melanoma, Stage II Melanoma in Situ Melanoma, Ocular

Start date: 2022-03-02
Primary completion: 2024-04-01
Enrollment: 1570

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.